Publications
How Valuable are Multiple Treatment Comparison Methods in Evidence-Based Health-Care Evaluation?
– Value in Health
(2011)
14,
371
(doi: 10.1016/j.jval.2010.09.001)
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
– Health Technology Assessment
(2011)
15,
i
(doi: 10.3310/hta15100)
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
– Health technology assessment (Winchester, England)
(2011)
15,
Quantifying uncertainty
(2011)
17
Barriers to Health Information and Building Solutions
– BETTER DOCTORS, BETTER PATIENTS, BETTER DECISIONS: ENVISIONING HEALTH CARE 2020
(2011)
191
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: A systematic review and economic evaluation
– Health Technology Assessment
(2011)
15,
134
(doi: 10.3310/hta15100)
Modelling Bias in Combining Small Area Prevalence Estimates from Multiple Surveys
– Journal of the Royal Statistical Society Series A Statistics in Society
(2010)
174,
31
Mathematics and medical statistics
(2010)
921
Summarizing historical information on controls in clinical trials
– Clin Trials
(2010)
7,
s5
(doi: 10.1177/1740774509356002)
Comments on 'A note on the power prior' Reply
– STATISTICS IN MEDICINE
(2010)
29,
709
- <
- 14 of 44